SWOG clinical trial number
SWOG-9059 (E-1392) (INT-0126)

Phase III Comparison of Standard Radiotherapy, versus Radiotherapy plus Simultaneous Cisplatin, versus Split-Course Radiotherapy plus Simultaneous Cisplatin and 5-Fluorouracil, in Patients with Unresectable Squamous Cell Carcinoma of the Head and Neck

Closed
Phase
Published
Abbreviated Title
Phase III Comparison of Standard Radiotherapy, versus Radiotherapy plus Simultaneous Cisplatin, versus Split-Course Radiotherapy plus Simultaneous Cisplatin and 5-Fluorouracil, in Patients with…
Activated
06/15/1992
Closed
11/29/1999

Research committees

Head and Neck Cancer

Publication Information Expand/Collapse

2003

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

DJ Adelstein;Y Li;GL Adams;H Wagner Jr;JA Kish;JF Ensley;DE Schuller;AA Forastiere Journal of Clinical Oncology 21(1):92-98

2000

A phase III comparison of standard radiation thereapy (RT) versus RT plus concurrent cisplatin (DDP) versus split-course RT plus concurrent DDP and 5-Fluorouracil (5FU) in patients with unresectable squamous cell head and neck cancer (SCHNC

DJ Adelstein;GL Adams;Y Li;H Wagner Jr;JA Kish;JF Ensley;DE Schuller;AA Forastiere Proc of the American Society of Clinical Oncology 19:411a(#1624)